Drug Testing Locations - Chalmette, LA

Drug Testing in Chalmette, LA

Chalmette, Louisiana Statistics

In Chalmette, LA, located in St. Bernard Parish, opioid-related overdose deaths accounted for 75% of all overdose deaths in 2020.

St. Bernard Parish reported a 25% increase in drug-related arrests in Chalmette, LA, between 2019 and 2021.

In 2021, approximately 5% of high school students in Chalmette, LA admitted to misusing prescription medication.

The rate of emergency room visits for drug overdoses in Chalmette, LA increased by 18% from 2020 to 2022.

Chalmette, LA has seen a growth in rehabilitation admissions, with a 15% increase from 2020 to 2022 for individuals seeking help.

Drug-related crime rates in Chalmette, LA have seen a 10% decline over the last year, indicating positive trends in law enforcement efforts.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Chalmette, LA & Drug Testing Policies

Employers in Chalmette, LA, recognize the importance of maintaining a drug-free workplace. To address substance abuse, many have implemented stringent drug testing policies in alignment with OSHA guidelines. This ensures the safety and productivity of their workforce.

Under the guidance of state policies, Chalmette businesses often conduct pre-employment and random drug testing. These measures aim to deter drug use and provide a safe environment for all employees, thereby improving overall workplace wellbeing and performance.

Government Efforts with Drug Problems in Chalmette, LA

The government of Chalmette, LA, in St. Bernard Parish, actively collaborates with local and state agencies to combat drug abuse. Partnerships with the Substance Abuse and Mental Health Services Administration provide crucial resources for addressing the growing drug issues in the area.

Local government initiatives in Chalmette focus on expanding access to treatment and support services. The St. Bernard Parish Council supports rehabilitation programs and educational campaigns aimed at preventing drug use among youth, offering a comprehensive approach to tackling the drug problem.

Local Drug Busts & News in Chalmette, LA

Recently, Chalmette, LA has been the site of significant drug busts, highlighting the ongoing efforts of law enforcement to tackle drug trafficking. In 2022, a major operation led to the arrest of multiple individuals involved in a regional drug ring.

The local police department continues to engage with the community, hosting events that encourage public participation in reporting suspicious activities. These efforts foster a collaborative environment that aids in reducing drug-related crime.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Chalmette, LA. Trusted by employers nationwide for accurate results and exceptional service.

Louisiana DOT/Non DOT Physicals

Louisiana Vision Tests

Louisiana Audiograms

Louisiana Respirator Fit Tests

Louisiana Lift Tests

Louisiana Background Checks

Clinical Testing Services

TB Testing in LA

Diabetes Testing in LA

Infectious Disease Testing in LA

Sickle Cell Anemia Testing in LA

Women/Men's Health Testing in LA

Resources & Citations

LA HUB

Orleans Parish Sheriff’s Office

Louisiana Council on Alcohol & Drug Abuse

Council on Alcohol and Drug Abuse for Greater New Orleans

Drug Free Louisiana

Louisiana Department of Health

Prevention Resource Center

Addiction Center - Inpatient Rehab

Northlake Behavioral Health System

Drug Testing Near Chalmette, LA

Marrero, LA

Saint Bernard, LA

Harvey, LA

Poydras, LA

New Orleans, LA

Belle Chasse, LA

Caernarvon, LA

Timberlane, LA

Gretna, LA

Braithwaite, LA

Saint Clair, LA

Violet, LA

English Turn, LA

Meraux, LA

Arabi, LA

Frequently Asked Questions

Customer Reviews